Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients: An age and gender matched case-control study

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1654-1661

  Kato, Shunji ^a   Onda, Masahiko ^a   Matsukura, Norio ^a   Tokunaga, Akira ^a   Matsuda, Noriko ^a   Yamashita, Kiyohiko ^a   Shields, Peter G ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cytochrome p450; gastric cancer susceptibility; genetic polymorphism; glutathione S transferase; Helicobacter pylori; L myc protooncogene

Indexed keywords

CYTOCHROME P450; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G; PEPSINOGEN I;

ADULT; AGED; AGING; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; RISK FACTOR; STATISTICAL ANALYSIS; STOMACH CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENE DELETION; GENES, MYC; GLUTATHIONE TRANSFERASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES, N-DEMETHYLATING; PEPSINOGENS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS;

EID: 0029937827     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1654::AID-CNCR35>3.0.CO;2-X     Document Type: Conference Paper

References (40)

1. Kuroishi T, Hirose K, Tajima K, Tominaga S. Cancer mortality in Japan (1950-1990). Cancer mortality and morbidity statistics: Japan and the world-1994. Gann Monograph on Cancer Research. No. 41. Tokyo: Japan Scientific Societies Press, 1994;41:1-105.
2. Kuroishi T, Hayakawa N, Kurihara M, Aoki K. Cancer mortality in 33 countries of the world (1953-1987). Cancer mortality and morbidity statistics: Japan and the world-1994. Gann Monograph on Cancer Research. No. 41. Tokyo: Japan Scientific Societies Press, 1994;41:167-230.
3. Cancer Rates and Risks. Public Health Service. NIH, Bethesda (MD): National Institutes of Health; 1985 NIH Pub. No. 85-691.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
5. Sato S, Fukuyama S, Susuki T, Takanagi J. The relationship between gastric cancer mortality and salted food intake in several places in Japan. Bull Inst Public Health 1959;8:187-98.
6. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
7. Ames B, Gold LS. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990;249:970-1.
8. Yang CS, Yoo J, Ishizaki H, Hong JY. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 1990;22:147-59.
9. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991;4:168-79.
10. Uematsu F, Kikuchi H, Motomiya M, Sagami T, Ohmachi T, Wakui A, et al. Association between restriction fragment length polymorphism of the human cytochrome p450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991;82:254-6.
11. Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, et al. Analysis of Cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarkers Prev 1994;3:515-8.
12. Sugimura H, Hamada GS, Suzuki I, Iwase T, Kiyokawa E, Kino I, et al. CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Riode Janeiro, Brazil. Pharmacogenetics 1995;5:S145-8.
13. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome p4502E1 gene. J Biochem (Tokyo) 1991;110:559-65.
14. Mannervic B, Danielson UH. Glutathione transferase: structure and catalytic activity. Crit Rev Biochem Mol Biol 1988;23:281-337.
15. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 1995;87:1246-53.
16. Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, et al. Glutathione S-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res 1995;55:2789-93.
17. Kawashima K, Shikama H, Imoto K, Izawa M, Naruke T, Okabayashi K, et al. Close correlation between restriction fragment length polymorphism of L-myc gene and metastasis of human lung cancer to the lymph nodes and other organs. Proc Natl Acad Sci USA 1988;85:2353-6.
18. Kawashima K, Nomura K, Hirai H, Fukushi S, Karube T, Takeuchi K, et al. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung cancer patients. Int J Cancer 1992;50:557-61.
19. Ishizuka K, Kato M, Ikenaga M, Honda K, Ozawa K, Toguchida I. Correlation of L-myc genotypes to metastasis of gastric cancer and breast cancer. J Natl Cancer Inst 1990;82:238-9.
20. Nomura A, Stemmermann GN, Chyou PK, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
21. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
22. Forman D, Newell DG, Fullerton F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. B M J 1991;302:1302-5.
23. Stemmermann GN. Intestinal metaplasia of the stomach. Cancer 1994;74:556-4.
24. Correa P, Haenszel W, Cuello C. Gastric precancerous process in an high risk population: cohort follow-up. Cancer Res 1990;65:2078-84.
25. Stemmermann GN, Samloff IM, Nomura AMY. Serum pepsinogen I and II and stomach cancer. Clin Chim Acta 1987;163:191-8.
26. Nomura AMY, Stemmermenn GN, Samloff IM. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980;93:537-40.
27. Miki K, Ichinose M, Kawamura N. The significance of low pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989;80:111-4.
28. Matsukura N, Onda M, Tokunaga A, Fujita I, Okuda T, Mizutani T, et al. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer and gastric cancer. J Clin Gastroenterol 1993;17:S146-50.
29. Japanese Classification of Gastric Carcinoma. Japanese Research Society for Gastric Cancer. First English Edition. Tokyo: Kanehara & Co. Ltd., 1994.
30. Sugimura H, Caporaso NE, Shaw GL, Modali RV, Gonzalez FJ, Hoover RN, et al. Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls. Carcinogenesis 1990;71:1527-30.
31. Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992;52:6712-5.
32. Tamai S, Sugimura H, Caporaso NE, Resau JH, Trump BF, Weston A, et al. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer. Int J Cancer 1990;46:411-5.
33. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 1993; 53:3486-92.
34. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335:1233-5.
35. Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev 1994;3:445-51.
36. Matsukura N, Onda M, Tokunaga A, Teramoto T, Fujita I, Okuda T, et al. Detection of serum IgG antibody against Helicobacter pylori from childhood in a Japanese population. J Gastroenterol 1994;29:403-5.
37. Asaka M, Kimura T, Kudo M, Terada H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to pepsinogen in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
38. Tsugane S, Tei Y, Takahashi T, Watanabe S, Sugano K. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 1994;85:474-8.
39. Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 1995;86:64-71.
40. Matsukura N, Onda M, Tokunaga A, Matsuda N, Yamashita K. Mucosal IgA antibody against Helicobacter pylori in chronic gastritis and intestinal metaplasia detected by the Tes-Tape method in resection specimens after gastrectomy for gastric cancer. Cancer 1995;75:1472-7.